HEADER VIRAL PROTEIN 06-DEC-06 2O5N TITLE CRYSTAL STRUCTURE OF A VIRAL GLYCOPROTEIN CAVEAT 2O5N NAG B 401 HAS WRONG CHIRALITY AT ATOM C1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: MUHV1GPM153; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MURID HERPESVIRUS 1; SOURCE 3 ORGANISM_COMMON: MURINE CYTOMEGALOVIRUS; SOURCE 4 ORGANISM_TAXID: 10366; SOURCE 5 STRAIN: SMITH; SOURCE 6 GENE: MUHV1GPM153; SOURCE 7 EXPRESSION_SYSTEM: DROSOPHILA MELANOGASTER; SOURCE 8 EXPRESSION_SYSTEM_COMMON: FRUIT FLY; SOURCE 9 EXPRESSION_SYSTEM_TAXID: 7227; SOURCE 10 EXPRESSION_SYSTEM_STRAIN: SCHNEIDER S2; SOURCE 11 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 12 EXPRESSION_SYSTEM_PLASMID: PMT/BIP/V5-HIS KEYWDS M153, MOUSE CYTOMEGALOVIRUS, MHC-I-LIKE, M145 FAMILY, MHC-IV, IG- KEYWDS 2 SUPERFAMILY, ALPHA-BETA PROTEIN, VIRAL PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR J.MANS,K.NATARAJAN,H.ROBINSON,D.H.MARGULIES REVDAT 9 27-DEC-23 2O5N 1 HETSYN REVDAT 8 29-JUL-20 2O5N 1 CAVEAT COMPND REMARK HET REVDAT 8 2 1 HETNAM FORMUL LINK SITE REVDAT 8 3 1 ATOM REVDAT 7 13-MAY-20 2O5N 1 COMPND REMARK LINK SITE REVDAT 7 2 1 ATOM REVDAT 6 18-OCT-17 2O5N 1 REMARK REVDAT 5 13-JUL-11 2O5N 1 VERSN REVDAT 4 24-FEB-09 2O5N 1 VERSN REVDAT 3 25-DEC-07 2O5N 1 JRNL REVDAT 2 30-OCT-07 2O5N 1 JRNL REVDAT 1 25-SEP-07 2O5N 0 JRNL AUTH J.MANS,K.NATARAJAN,A.BALBO,P.SCHUCK,D.EIKEL,S.HESS, JRNL AUTH 2 H.ROBINSON,H.SIMIC,S.JONJIC,C.T.TIEMESSEN,D.H.MARGULIES JRNL TITL CELLULAR EXPRESSION AND CRYSTAL STRUCTURE OF THE MURINE JRNL TITL 2 CYTOMEGALOVIRUS MAJOR HISTOCOMPATIBILITY COMPLEX CLASS JRNL TITL 3 I-LIKE GLYCOPROTEIN, M153. JRNL REF J.BIOL.CHEM. V. 282 35247 2007 JRNL REFN ISSN 0021-9258 JRNL PMID 17897947 JRNL DOI 10.1074/JBC.M706782200 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REFMAC_5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 62.75 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 23443 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.233 REMARK 3 R VALUE (WORKING SET) : 0.230 REMARK 3 FREE R VALUE : 0.279 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1183 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.46 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1559 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.53 REMARK 3 BIN R VALUE (WORKING SET) : 0.2520 REMARK 3 BIN FREE R VALUE SET COUNT : 86 REMARK 3 BIN FREE R VALUE : 0.3300 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4255 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 81 REMARK 3 SOLVENT ATOMS : 57 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.55 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.35000 REMARK 3 B22 (A**2) : 0.41000 REMARK 3 B33 (A**2) : -0.75000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.61000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.546 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.303 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.214 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 8.868 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.919 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.876 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4431 ; 0.010 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6041 ; 1.318 ; 1.967 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 542 ; 6.974 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 196 ;37.443 ;24.337 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 726 ;16.513 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 30 ;18.267 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 708 ; 0.087 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3292 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1787 ; 0.208 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2976 ; 0.303 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 171 ; 0.154 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 39 ; 0.212 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 6 ; 0.080 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2810 ; 0.719 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4420 ; 1.153 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1868 ; 1.553 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1621 ; 2.531 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS, REMARK 3 RESIDUES WITH MISSING SIDECHAIN DENSITY WERE MODELLED AS ALANINE REMARK 3 FOR REFINEMENT REMARK 4 REMARK 4 2O5N COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-DEC-06. REMARK 100 THE DEPOSITION ID IS D_1000040717. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-APR-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X29A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9791 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO, HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK, HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26191 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 62.750 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.5 REMARK 200 DATA REDUNDANCY : 12.80 REMARK 200 R MERGE (I) : 0.08100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.38 REMARK 200 COMPLETENESS FOR SHELL (%) : 80.6 REMARK 200 DATA REDUNDANCY IN SHELL : 4.90 REMARK 200 R MERGE FOR SHELL (I) : 0.40400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.540 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: SOLVE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.73 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.08 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25 % PEG 2000 MME, 0.1M TRIS-HCL, 0.5 REMARK 280 % N-DODECYL-B-D-MALTOSIDE, PH 8.5, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 39.08900 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3400 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 25900 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 9.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 1 REMARK 465 ASP A 232 REMARK 465 TYR A 233 REMARK 465 TYR A 234 REMARK 465 THR A 235 REMARK 465 ASP A 236 REMARK 465 LYS A 278 REMARK 465 ALA A 279 REMARK 465 ARG A 280 REMARK 465 GLN A 281 REMARK 465 ALA A 282 REMARK 465 GLN A 283 REMARK 465 LYS A 284 REMARK 465 ARG A 285 REMARK 465 PRO A 286 REMARK 465 LEU A 287 REMARK 465 LEU A 288 REMARK 465 PRO A 289 REMARK 465 VAL A 290 REMARK 465 GLU A 291 REMARK 465 PRO A 292 REMARK 465 HIS A 293 REMARK 465 GLY A 294 REMARK 465 PHE A 295 REMARK 465 MET A 296 REMARK 465 SER A 297 REMARK 465 ASP A 298 REMARK 465 GLU A 299 REMARK 465 HIS A 300 REMARK 465 GLY A 301 REMARK 465 PRO A 302 REMARK 465 ALA A 303 REMARK 465 PHE A 304 REMARK 465 VAL A 305 REMARK 465 GLN A 306 REMARK 465 ARG A 307 REMARK 465 THR A 308 REMARK 465 ILE A 309 REMARK 465 ASN A 310 REMARK 465 ASP A 311 REMARK 465 SER A 312 REMARK 465 ARG A 313 REMARK 465 LEU A 314 REMARK 465 THR A 315 REMARK 465 LEU A 316 REMARK 465 VAL A 317 REMARK 465 PRO A 318 REMARK 465 ARG A 319 REMARK 465 GLU B 1 REMARK 465 VAL B 2 REMARK 465 VAL B 3 REMARK 465 ARG B 4 REMARK 465 ALA B 279 REMARK 465 ARG B 280 REMARK 465 GLN B 281 REMARK 465 ALA B 282 REMARK 465 GLN B 283 REMARK 465 LYS B 284 REMARK 465 ARG B 285 REMARK 465 PRO B 286 REMARK 465 LEU B 287 REMARK 465 LEU B 288 REMARK 465 PRO B 289 REMARK 465 VAL B 290 REMARK 465 GLU B 291 REMARK 465 PRO B 292 REMARK 465 HIS B 293 REMARK 465 GLY B 294 REMARK 465 PHE B 295 REMARK 465 MET B 296 REMARK 465 SER B 297 REMARK 465 ASP B 298 REMARK 465 GLU B 299 REMARK 465 HIS B 300 REMARK 465 GLY B 301 REMARK 465 PRO B 302 REMARK 465 ALA B 303 REMARK 465 PHE B 304 REMARK 465 VAL B 305 REMARK 465 GLN B 306 REMARK 465 ARG B 307 REMARK 465 THR B 308 REMARK 465 ILE B 309 REMARK 465 ASN B 310 REMARK 465 ASP B 311 REMARK 465 SER B 312 REMARK 465 ARG B 313 REMARK 465 LEU B 314 REMARK 465 THR B 315 REMARK 465 LEU B 316 REMARK 465 VAL B 317 REMARK 465 PRO B 318 REMARK 465 ARG B 319 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 VAL A 2 CG1 CG2 REMARK 470 ARG A 9 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 17 CG CD OE1 NE2 REMARK 470 LYS A 41 CG CD CE NZ REMARK 470 GLU A 59 CG CD OE1 OE2 REMARK 470 LYS A 83 CG CD CE NZ REMARK 470 THR A 138 OG1 CG2 REMARK 470 GLN A 184 CG CD OE1 NE2 REMARK 470 GLU A 188 CG CD OE1 OE2 REMARK 470 ILE A 196 CG1 CG2 CD1 REMARK 470 GLN A 208 CG CD OE1 NE2 REMARK 470 ILE A 237 CG1 CG2 CD1 REMARK 470 ILE A 250 CG1 CG2 CD1 REMARK 470 GLU B 117 CG CD OE1 OE2 REMARK 470 THR B 138 OG1 CG2 REMARK 470 LYS B 139 CG CD CE NZ REMARK 470 GLN B 184 CG CD OE1 NE2 REMARK 470 TYR B 234 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 THR B 235 OG1 CG2 REMARK 470 LYS B 278 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O PRO A 102 N PHE A 106 2.07 REMARK 500 ND2 ASN A 107 C2 NAG C 1 2.15 REMARK 500 ND2 ASN B 107 C2 NAG B 401 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 51 45.22 35.74 REMARK 500 THR A 57 -154.16 -148.09 REMARK 500 PHE A 106 4.98 80.35 REMARK 500 VAL A 132 19.92 -150.85 REMARK 500 ASP A 178 78.30 -69.29 REMARK 500 ASP A 189 -164.98 -113.21 REMARK 500 ASP B 123 -84.89 -92.78 REMARK 500 SER B 134 40.39 -70.16 REMARK 500 ASP B 189 -157.42 -107.08 REMARK 500 PRO B 210 48.06 -80.76 REMARK 500 TYR B 233 43.82 -100.92 REMARK 500 TYR B 234 89.14 62.44 REMARK 500 ASP B 236 114.81 -168.10 REMARK 500 ALA B 275 88.40 -59.28 REMARK 500 ALA B 276 91.33 176.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 999 REMARK 999 SEQUENCE REMARK 999 NO SUITABLE DATABASE REFERENCES WERE FOUND AT TIME REMARK 999 OF PROCESSING. DBREF 2O5N A 1 319 PDB 2O5N 2O5N 1 319 DBREF 2O5N B 1 319 PDB 2O5N 2O5N 1 319 SEQRES 1 A 319 GLU VAL VAL ARG PRO GLU VAL ASN ARG THR GLY THR VAL SEQRES 2 A 319 ASP ILE CYS GLN GLY PRO MSE GLU LEU ILE PHE SER VAL SEQRES 3 A 319 SER ARG THR SER SER GLY ALA THR GLY GLU ARG ILE SER SEQRES 4 A 319 LEU LYS ASN THR LEU SER ILE VAL SER MSE GLU ASN GLY SEQRES 5 A 319 GLY LYS PRO GLY THR TYR GLU TRP SER PHE PRO ALA ASN SEQRES 6 A 319 GLU SER TRP PRO GLU ILE GLN PHE LEU LEU GLN ASN ARG SEQRES 7 A 319 GLU PHE VAL SER LYS TYR TYR ALA ASP VAL VAL GLN THR SEQRES 8 A 319 PRO GLY GLU LEU VAL VAL GLU TYR ARG CYS PRO VAL PRO SEQRES 9 A 319 GLN PHE ASN CYS THR ILE THR HIS ARG TRP LYS GLY GLU SEQRES 10 A 319 THR ILE MSE SER PHE ASP GLY ALA ILE GLN THR ILE ARG SEQRES 11 A 319 SER VAL THR SER GLU TYR THR THR LYS ASN GLU ASP THR SEQRES 12 A 319 LEU VAL LYS TYR ILE ARG GLY LEU ASN VAL THR LEU LEU SEQRES 13 A 319 THR ASP ASN ALA LYS SER ILE GLU HIS ARG TRP THR GLU SEQRES 14 A 319 ILE CYS LYS LYS LEU LYS ASP ALA ASP ARG PRO ASP ASP SEQRES 15 A 319 ASN GLN TYR THR LEU GLU ASP ASP ILE LEU GLU ASP ASP SEQRES 16 A 319 ILE GLU MSE ASP ILE VAL GLN CYS GLN MSE THR THR GLN SEQRES 17 A 319 VAL PRO LEU LYS TYR HIS MSE THR VAL TRP SER ALA GLY SEQRES 18 A 319 ARG ASP SER ARG ALA ILE ALA LEU SER ALA ASP TYR TYR SEQRES 19 A 319 THR ASP ILE GLU VAL ALA SER TYR LEU PRO VAL ASN ARG SEQRES 20 A 319 SER GLN ILE LEU ASN THR THR CYS GLU ILE THR SER SER SEQRES 21 A 319 SER GLY TRP THR VAL ARG LEU ARG PHE SER GLU GLU MSE SEQRES 22 A 319 VAL ALA ALA SER LYS ALA ARG GLN ALA GLN LYS ARG PRO SEQRES 23 A 319 LEU LEU PRO VAL GLU PRO HIS GLY PHE MET SER ASP GLU SEQRES 24 A 319 HIS GLY PRO ALA PHE VAL GLN ARG THR ILE ASN ASP SER SEQRES 25 A 319 ARG LEU THR LEU VAL PRO ARG SEQRES 1 B 319 GLU VAL VAL ARG PRO GLU VAL ASN ARG THR GLY THR VAL SEQRES 2 B 319 ASP ILE CYS GLN GLY PRO MSE GLU LEU ILE PHE SER VAL SEQRES 3 B 319 SER ARG THR SER SER GLY ALA THR GLY GLU ARG ILE SER SEQRES 4 B 319 LEU LYS ASN THR LEU SER ILE VAL SER MSE GLU ASN GLY SEQRES 5 B 319 GLY LYS PRO GLY THR TYR GLU TRP SER PHE PRO ALA ASN SEQRES 6 B 319 GLU SER TRP PRO GLU ILE GLN PHE LEU LEU GLN ASN ARG SEQRES 7 B 319 GLU PHE VAL SER LYS TYR TYR ALA ASP VAL VAL GLN THR SEQRES 8 B 319 PRO GLY GLU LEU VAL VAL GLU TYR ARG CYS PRO VAL PRO SEQRES 9 B 319 GLN PHE ASN CYS THR ILE THR HIS ARG TRP LYS GLY GLU SEQRES 10 B 319 THR ILE MSE SER PHE ASP GLY ALA ILE GLN THR ILE ARG SEQRES 11 B 319 SER VAL THR SER GLU TYR THR THR LYS ASN GLU ASP THR SEQRES 12 B 319 LEU VAL LYS TYR ILE ARG GLY LEU ASN VAL THR LEU LEU SEQRES 13 B 319 THR ASP ASN ALA LYS SER ILE GLU HIS ARG TRP THR GLU SEQRES 14 B 319 ILE CYS LYS LYS LEU LYS ASP ALA ASP ARG PRO ASP ASP SEQRES 15 B 319 ASN GLN TYR THR LEU GLU ASP ASP ILE LEU GLU ASP ASP SEQRES 16 B 319 ILE GLU MSE ASP ILE VAL GLN CYS GLN MSE THR THR GLN SEQRES 17 B 319 VAL PRO LEU LYS TYR HIS MSE THR VAL TRP SER ALA GLY SEQRES 18 B 319 ARG ASP SER ARG ALA ILE ALA LEU SER ALA ASP TYR TYR SEQRES 19 B 319 THR ASP ILE GLU VAL ALA SER TYR LEU PRO VAL ASN ARG SEQRES 20 B 319 SER GLN ILE LEU ASN THR THR CYS GLU ILE THR SER SER SEQRES 21 B 319 SER GLY TRP THR VAL ARG LEU ARG PHE SER GLU GLU MSE SEQRES 22 B 319 VAL ALA ALA SER LYS ALA ARG GLN ALA GLN LYS ARG PRO SEQRES 23 B 319 LEU LEU PRO VAL GLU PRO HIS GLY PHE MET SER ASP GLU SEQRES 24 B 319 HIS GLY PRO ALA PHE VAL GLN ARG THR ILE ASN ASP SER SEQRES 25 B 319 ARG LEU THR LEU VAL PRO ARG MODRES 2O5N ASN A 107 ASN GLYCOSYLATION SITE MODRES 2O5N ASN B 252 ASN GLYCOSYLATION SITE MODRES 2O5N ASN B 107 ASN GLYCOSYLATION SITE MODRES 2O5N MSE A 20 MET SELENOMETHIONINE MODRES 2O5N MSE A 49 MET SELENOMETHIONINE MODRES 2O5N MSE A 120 MET SELENOMETHIONINE MODRES 2O5N MSE A 198 MET SELENOMETHIONINE MODRES 2O5N MSE A 205 MET SELENOMETHIONINE MODRES 2O5N MSE A 215 MET SELENOMETHIONINE MODRES 2O5N MSE A 273 MET SELENOMETHIONINE MODRES 2O5N MSE B 20 MET SELENOMETHIONINE MODRES 2O5N MSE B 49 MET SELENOMETHIONINE MODRES 2O5N MSE B 120 MET SELENOMETHIONINE MODRES 2O5N MSE B 198 MET SELENOMETHIONINE MODRES 2O5N MSE B 205 MET SELENOMETHIONINE MODRES 2O5N MSE B 215 MET SELENOMETHIONINE MODRES 2O5N MSE B 273 MET SELENOMETHIONINE HET MSE A 20 8 HET MSE A 49 8 HET MSE A 120 8 HET MSE A 198 8 HET MSE A 205 8 HET MSE A 215 8 HET MSE A 273 8 HET MSE B 20 8 HET MSE B 49 8 HET MSE B 120 8 HET MSE B 198 8 HET MSE B 205 8 HET MSE B 215 8 HET MSE B 273 8 HET NAG C 1 14 HET NAG C 2 14 HET BMA C 3 11 HET NAG D 1 14 HET NAG D 2 14 HET NAG B 401 14 HETNAM MSE SELENOMETHIONINE HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE FORMUL 1 MSE 14(C5 H11 N O2 SE) FORMUL 3 NAG 5(C8 H15 N O6) FORMUL 3 BMA C6 H12 O6 FORMUL 6 HOH *57(H2 O) HELIX 1 1 TRP A 68 VAL A 89 1 22 HELIX 2 2 VAL A 132 TYR A 136 5 5 HELIX 3 3 ASN A 140 LYS A 146 1 7 HELIX 4 4 VAL A 153 ASN A 159 1 7 HELIX 5 5 ASN A 159 ASP A 178 1 20 HELIX 6 6 ARG A 179 ASN A 183 5 5 HELIX 7 7 SER A 248 ILE A 250 5 3 HELIX 8 8 SER A 270 ALA A 276 1 7 HELIX 9 9 TRP B 68 VAL B 89 1 22 HELIX 10 10 VAL B 132 TYR B 136 5 5 HELIX 11 11 ASN B 140 VAL B 145 1 6 HELIX 12 12 VAL B 153 ASP B 158 1 6 HELIX 13 13 ASN B 159 ASP B 178 1 20 HELIX 14 14 ARG B 179 ASN B 183 5 5 HELIX 15 15 SER B 248 ILE B 250 5 3 HELIX 16 16 SER B 270 ALA B 275 1 6 SHEET 1 A12 GLU A 6 ASN A 8 0 SHEET 2 A12 THR A 264 ARG A 268 -1 O THR A 264 N ASN A 8 SHEET 3 A12 THR A 254 SER A 259 -1 N ILE A 257 O VAL A 265 SHEET 4 A12 TYR A 213 TRP A 218 -1 N THR A 216 O GLU A 256 SHEET 5 A12 SER A 224 LEU A 229 -1 O ALA A 228 N MSE A 215 SHEET 6 A12 GLN B 127 ARG B 130 1 O GLN B 127 N ARG A 225 SHEET 7 A12 GLU B 117 PHE B 122 -1 N SER B 121 O THR B 128 SHEET 8 A12 THR B 109 TRP B 114 -1 N TRP B 114 O GLU B 117 SHEET 9 A12 LEU B 95 PRO B 102 -1 N ARG B 100 O THR B 109 SHEET 10 A12 GLU B 21 ARG B 28 -1 N VAL B 26 O VAL B 97 SHEET 11 A12 THR B 34 LEU B 40 -1 O SER B 39 N ILE B 23 SHEET 12 A12 VAL B 47 GLU B 50 -1 O VAL B 47 N ILE B 38 SHEET 1 B12 VAL A 47 GLU A 50 0 SHEET 2 B12 THR A 34 LEU A 40 -1 N ILE A 38 O VAL A 47 SHEET 3 B12 GLU A 21 ARG A 28 -1 N ILE A 23 O SER A 39 SHEET 4 B12 LEU A 95 PRO A 102 -1 O LEU A 95 N ARG A 28 SHEET 5 B12 THR A 109 TRP A 114 -1 O ARG A 113 N VAL A 96 SHEET 6 B12 GLU A 117 PHE A 122 -1 O GLU A 117 N TRP A 114 SHEET 7 B12 GLN A 127 ARG A 130 -1 O THR A 128 N SER A 121 SHEET 8 B12 SER B 224 LEU B 229 1 O ILE B 227 N ILE A 129 SHEET 9 B12 TYR B 213 TRP B 218 -1 N MSE B 215 O ALA B 228 SHEET 10 B12 THR B 254 SER B 259 -1 O THR B 254 N TRP B 218 SHEET 11 B12 THR B 264 ARG B 268 -1 O LEU B 267 N CYS B 255 SHEET 12 B12 GLU B 6 ASN B 8 -1 N ASN B 8 O THR B 264 SHEET 1 C 3 GLN A 184 GLU A 188 0 SHEET 2 C 3 MSE A 198 THR A 206 -1 O GLN A 202 N GLU A 188 SHEET 3 C 3 GLU A 238 ASN A 246 -1 O LEU A 243 N VAL A 201 SHEET 1 D 4 GLN B 184 GLU B 188 0 SHEET 2 D 4 MSE B 198 THR B 206 -1 O GLN B 202 N GLU B 188 SHEET 3 D 4 ILE B 237 ASN B 246 -1 O LEU B 243 N VAL B 201 SHEET 4 D 4 ALA B 231 ASP B 232 -1 N ALA B 231 O GLU B 238 SSBOND 1 CYS A 16 CYS A 171 1555 1555 2.07 SSBOND 2 CYS A 101 CYS A 108 1555 1555 2.06 SSBOND 3 CYS A 203 CYS A 255 1555 1555 2.05 SSBOND 4 CYS B 16 CYS B 171 1555 1555 2.07 SSBOND 5 CYS B 101 CYS B 108 1555 1555 2.09 SSBOND 6 CYS B 203 CYS B 255 1555 1555 2.04 LINK C PRO A 19 N MSE A 20 1555 1555 1.33 LINK C MSE A 20 N GLU A 21 1555 1555 1.33 LINK C SER A 48 N MSE A 49 1555 1555 1.33 LINK C MSE A 49 N GLU A 50 1555 1555 1.33 LINK ND2 ASN A 107 C1 NAG C 1 1555 1555 1.45 LINK C ILE A 119 N MSE A 120 1555 1555 1.34 LINK C MSE A 120 N SER A 121 1555 1555 1.33 LINK C GLU A 197 N MSE A 198 1555 1555 1.33 LINK C MSE A 198 N ASP A 199 1555 1555 1.33 LINK C GLN A 204 N MSE A 205 1555 1555 1.33 LINK C MSE A 205 N THR A 206 1555 1555 1.33 LINK C HIS A 214 N MSE A 215 1555 1555 1.33 LINK C MSE A 215 N THR A 216 1555 1555 1.34 LINK C GLU A 272 N MSE A 273 1555 1555 1.33 LINK C MSE A 273 N VAL A 274 1555 1555 1.33 LINK C PRO B 19 N MSE B 20 1555 1555 1.33 LINK C MSE B 20 N GLU B 21 1555 1555 1.33 LINK C SER B 48 N MSE B 49 1555 1555 1.33 LINK C MSE B 49 N GLU B 50 1555 1555 1.32 LINK ND2 ASN B 107 C1 NAG B 401 1555 1555 1.45 LINK C ILE B 119 N MSE B 120 1555 1555 1.33 LINK C MSE B 120 N SER B 121 1555 1555 1.33 LINK C GLU B 197 N MSE B 198 1555 1555 1.33 LINK C MSE B 198 N ASP B 199 1555 1555 1.33 LINK C GLN B 204 N MSE B 205 1555 1555 1.33 LINK C MSE B 205 N THR B 206 1555 1555 1.33 LINK C HIS B 214 N MSE B 215 1555 1555 1.33 LINK C MSE B 215 N THR B 216 1555 1555 1.32 LINK ND2 ASN B 252 C1 NAG D 1 1555 1555 1.44 LINK C GLU B 272 N MSE B 273 1555 1555 1.33 LINK C MSE B 273 N VAL B 274 1555 1555 1.33 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.44 LINK O4 NAG C 2 C1 BMA C 3 1555 1555 1.44 LINK O4 NAG D 1 C1 NAG D 2 1555 1555 1.45 CISPEP 1 VAL A 103 PRO A 104 0 11.50 CISPEP 2 GLN A 105 PHE A 106 0 25.56 CISPEP 3 VAL B 103 PRO B 104 0 4.39 CRYST1 61.969 78.178 62.726 90.00 90.43 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016137 0.000000 0.000121 0.00000 SCALE2 0.000000 0.012791 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015943 0.00000